As an example, a meta-analysis of 48 trials that compared ACE inhibitors or ARBs with either placebo or another antihypertensive drug found that ACE inhibitors significantly reduced mortality compared with placebo (9.3 versus 10.5 percent) but that ARBs did not reduce mortality compared with placebo (5 versus 5 percent) [55].